[172]Y.Kawashima,T.Handa,H.Takenaka,S.Y.Lin,Y.Ando,Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan,J.Pharm.Sci.74(1985)264–268. [173]T.H.Dung,S.R.Lee,S.D.Han,S.J.Kim,Y.M.Ju,M.S.Kim,H.Yoo,Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment,J.Nanosci.Nanotechnol.7(2007)3695–3699.
[174]Q.Gan,T.Wang,C.Cochrane,P.McCarron,Modulation of surface charge,particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery,Colloids Surf.B Biointerfaces44(2005)65–73.
[175]R.Fernandez-Urrusuno,P.Cavlo,C.Remunan-Lopez,J.L.Vila-Jato,M.J.Alonso, Enhancement of nasal absorption of insulin using chitosan nanoparticles,Pharm.
Res.16(1999)1576–1581.
[176]Y.Pan,Y.Li,H.Zhao,J.Zheng,H.Xu,G.Wei,J.Hao,F.Cui,Chitosan nanoparticles improve the intestinal absorption of insulin in vivo,Int.J.Pharm.249(2002)139–147. [177]Y.Xu,Y.Du,Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles,Int.J.Pharm.250(2003)215–226. [178]A.Berthold,K.Cremer,J.Kreuter,Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-in?ammatory drugs,J.Control.Release39(1996)17–25.
[179]X.X.Tian,M.J.Groves,Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles, J.Pharm.Pharmacol.51(1999)151–157.
[180]K.Ray,H.Q.Mao,K.Y.Lin,S.K.Huang,K.W.Leong,Oral immunization with DNA-chitosan nanoparticles,Proc.Int.Symp.Control.Release Mater.26(1999)348–349. [181]H.Tokumitsu,H.Ichikawa,Y.Fukumori,Chitosan–gadopentetic acid complex nanoparticles for gadolinium neutron capture therapy of cancer:preparation by novel emulsion-droplet coalescence technique and characterization,Pharm.Res.
16(1999)1830–1835.
[182]Y.S.Leong,F.Candau,Inverse microemulsion polymerization,J.Phys.Chem.86 (1982)2269–2271.
[183]A.Maitra,Determination of size parameters of water–Aerosol OT–oil reverse micelles from their nuclear magnetic resonance data,J.Phys.Chem.88(1984) 5122–5125.
[184]P.L.Luisi,M.Giomini,M.P.Pileni,B.H.Robinson,Reverse micelles as hosts for proteins and small molecules,Biochim.Biophys.Acta947(1988)209–246. [185]S.Mitra,U.Gaur,P.C.Ghosh,A.N.Maitra,Tumor targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier,J.Control.
Release74(2001)317–323.
[186]S.Yu,J.Hu,X.Pan,P.Yao,M.Jiang,Stable and pH-sensitive nanogels prepared by self-assembly of chitosan and ovalbumin,Langmuir22(2006)2754–2759. [187]S.Ichikawa,S.Iwamoto,J.Watanabe,Formation of biocompatible nanoparticles by self-assembly of enzymatic hydrolysates of chitosan and carboxymethyl cellulose,Biosci.Biotechnol.Biochem.69(2005)1637–1642.
[188]Y.Ohya,R.Cai,H.Nishizawa,K.Hara,T.Ouchi,Preparation of PEG-grafted chitosan nano-particle for peptide drug carrier,Proc.Int.Symp.Control.Release Bioact.Mater.26(1999)655–656.
[189]I.F.Uchegbu,A.G.Schätzlein,L.Tetley,A.I.Gray,J.Sludden,S.Siddique,E.Mosha, Polymeric chitosan-based vesicles for drug delivery,J.Pharm.Pharmacol.50 (1998)453–458.
[190]K.Y.Lee,I.C.Kwon,Y.-H.Kim,W.H.Jo,S.Y.Jeong,Preparation of chitosan self-aggregates as a gene delivery system,J.Control.Release51(1998)213–220. [191]K.Y.Lee,I.C.Kwon,Y.-H.Kim,W.H.Jo,S.Y.Jeong,Structural investigation of chitosan self-aggregates prepared for gene delivery,Proc.Int.Symp.Control.Rel.
Bioact.Mater.25(1998)340–341.
[192]H.H.Tonnesen,J.Karlsen,Alginate in drug delivery systems,Drug Dev.Ind.
Pharm.28(2002)621–630.
[193]M.Rajaonarivony,C.Vauthier,G.Couarraze,F.Puisieux,P.Couvreur,Develop-ment of a new drug carrier made from alginate,J.Pharm.Sci.82(9)(1993) 912–917.
[194]Y.M.Yi,T.Y.Yang,W.M.Pan,Preparation and distribution of5-?uorouracil(125)I sodium alginate-bovine serum albumin nanoparticles,World J.Gastroenterol.5(1) (1999)57–60.
[195]I.Aynié, C.Vauthier,H.Chacun, E.Fattal,P.Couvreur,Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides,Antisense Nucleic Acid Drug Dev.9(3)(1999)301–312. [196]B.Sarmento,A.J.Ribeiro,F.Veiga,D.C.Ferreira,Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems,Biomed.Chromatogr.20(9)(2006)898–903.
[197]B.Sarmento, A.J.Ribeiro, F.Veiga, D.C.Ferreira,R.J.Neufeld,Insulin-loaded nanoparticles are prepared by alginate ionotropic pregelation followed by chitosan polyelectrolyte complexation,J.Nanosci.Nanotechnol.7(8)(2007) 2833–2841.
[198]C.P.Reis,A.J.Ribeiro,S.Houng,F.Veiga,R.J.Neufeld,Nanoparticulate delivery system for insulin:design,characterization and in vitro/in vivo bioactivity,Eur.J.
Pharm.Sci.30(5)(2007)392–397.
[199]Z.Ahmad,R.Pandey,S.Sharma,G.K.Khuller,Pharmacokinetic and pharmaco-dynamic behaviour of antitubercular drugs encapsulated in alginate nanoparti-cles at two doses,Int.J.Antimicrob.Agents27(2006)409–416.
[200]R.Pandey,G.K.Khuller,Nanotechnology based drug delivery system(s)for the management of tuberculosis,Indian J.Exp.Biol.44(5)(2006)357–366. [201]Z.Ahmad,S.Sharma,G.K.Khuller,Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis,Nanomedicine3(3)(2007)239–243.
[202]Z.Ahmad,S.Sharma,G.K.Khuller,Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis,Int.J.Antimicrob.
Agents26(4)(2005)298–303.[203]K.L.Douglas,C.A.Piccirillo,M.Tabrizian,Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles,J.Control.Release115(3) (2006)354–361.
[204]M.Boissière,J.Allouche,C.Chanéac,R.Brayner,J.M.Devoisselle,J.Livage,T.Coradin, Potentialities of silica/alginate nanoparticles as hybrid magnetic carriers,Int.J.
Pharm.344(1–2)(2007)128–134.
[205]A.Pal,K.Esumi,Photochemical synthesis of biopolymer coated Aucore–Agshell type bimetallic nanoparticles,J.Nanosci.Nanotechnol.7(6)(2007)2110–2115. [206]R.Guo,L.Zhang,Z.Jiang,Y.Cao,Y.Ding,X.Jiang,Synthesis of alginic acid-poly[2-(diethylamino)ethyl methacrylate]monodispersed nanoparticles by a polymer–monomer pair reaction system,Biomacromolecules8(3)(2007)843–850. [207]C.M.Hassan,N.A.Peppas,Structure and applications of poly(vinyl alcohol) hydrogels produced by conventional crosslinking or by freeze/thawing methods, in:J.Y.Chang,D.Y.Godovsky,M.J.Han,C.M.Hassan,J.Kim,B.Lee,Y.Lee,N.A.
Peppas,R.P.Quirk,T.Yoo(Eds.),Biopolymers PVA Hydrogels,Anionic Polymer-isation Nanocomposites,Advances in Polymer Science,vol.153,Springer,Berlin, 2000,pp.37–65.
[208]J.K.Li,N.Wang,X.S.Wu,Poly(vinyl alcohol)nanoparticles prepared by freezing–thawing process for protein/peptide drug delivery,J.Control Release56(1998) 117–126.
[209]S.A.Galindo Rodríguez,F.Puel,S.Briancon,E.Allémann,E.Doelker,H.Fessi, Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles,Eur.J.Pharm.Sci.25(4–5)(2005)357–367.
[210]K.S.Soppimath,T.M.Aminabhavi,A.R.Kulkarni,W.E.Rudzinski,Biodegradable polymeric nanoparticles as drug delivery devices,J.Control.Release70(1–2) (2001)1–20.
[211]T.Jung,A.Breitenbach,T.Kissel,Sulfobutylated poly(vinyl alcohol)-grafted-poly (lactide-coglycolide)facilitate the preparation of small negatively charged biode-gradable nanospheres for protein delivery,J.Control.Release67(2000)157–169. [212]A.Breitenbach,G.Nykamp,T.Kissel,Self-assembling colloidal carriers for protein delivery:nanoparticulate polymer protein conjugates with novel water soluble biodegradable comb polyesters,Proc.Int.Symp.Control.Release Bioact.Mater.26 (1999)150–160.
[213]M.A.Breitenbach,W.Kamm,K.D.Hungere,E.Hund,T.Kissel,Oral and nasal administration of tetanus toxoid loaded nanoparticles consisting of novel charged biodegradable polyesters for mucosal vaccination,Proc.Intern.Symp.
Control.Release.Bioact.Mater.26(1999)348–349.
[214]N.Wang,X.S.Wu,J.K.Li,A heterogeneously structured composite based on poly (lactic-co-glycolic acid)microspheres and poly(vinyl alcohol)hydrogel nanopar-ticles for long-term protein drug delivery,Pharm.Res.16(9)(1999)1430–1435. [215]H.Vihola,ukkanen,J.Hirovonen,H.Tenhu,Binding and release of drugs into and from thermosensitive poly(N-vinyl caprolactam)nanoparticles,Eur.J.Pharm.
Sci.16(1–2)(2002)69–74.
[216]L.A.Dailey,E.Kleemann,M.Wittmar,T.Gessler,T.Schmehl,C.Roberts,W.Seeger, T.Kissel,Surfactant free,biodegradable nanoparticles for aerosol therapy based on branched polyesters,DEAPA-PVAL-g-PLGA,Pharm.Res.20(12)(2003) 2011–2020.
[217]C.G.Oster,M.Wittmar,U.Bakowsky,T.Kissel,DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modi?ed solvent displacement method,J.Control.Release111(3)(2006)371–381.
[218]U.Westedt,M.Kalinowski,M.Wittmar,T.Merdan,F.Unger,J.Fuchs,S.Schäller, U.Bakowsky,T.Kissel,Poly(vinyl alcohol)-grafted-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment,J.Control.
Release119(1)(2007)41–51.
[219]S.V.Vinogradov,T.K.Bronich,A.V.Kabanov,Nanosized cationic hydrogels for drug delivery:preparation,properties and interactions with cells,Adv.Drug Deliv.Rev.
54(2002)135–147.
[220]S.Vinogradov,E.Batrakova,A.Kabanov,Poly(ethyleneglycol)-polyethylenimine nanogel particles:novel drug delivery systems for antisense oligonucleotides, Colloids Surf.16(1999)291–304.
[221]T.K.Bronich,S.V.Vinogradov,A.V.Kabanov,Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules,Nano Lett.1(2001) 535–540.
[222]A.V.Kabanov,Taking polycation gene delivery systems from in vitro to in vivo, Pharm.Sci.Technol.Today2(1999)365–372.
[223]E.D.Goddard,K.P.Ananthapadmanabhan(Eds.),Interactions of Surfactants with Polymers and Proteins,CRC Press,Boca Raton,FL,1993.
[224]T.K.Bronich,S.V.Vinogradov,A.V.Kabanov,Interaction of nanosized copolymer networks with oppositely charged amphiphilic molecules,Nano Lett.1(2001) 535–540.
[225]V.A.Kabanov,A.B.Zezin,V.B.Rogacheva,Y.V.Khandurina,O.A.Novoskoltseva, Absorption of ionic amphiphiles by oppositely charged polyelectrolyte gels, Macromol.Symp.126(1997)79–94.
[226]P.J.Watts,M.C.Davies,C.D.Melia,Microencapsulation using emulsi?cation/ solvent evaporation:an overview of techniques and applications,Crit.Rev.Ther.
Drug Carr.Syst.7(1990)235–259.
[227]B.V.Roninson,F.M.Sullivan,J.F.Borzelleca,S.L.Schwartz,PVP,A Critical Review of the Kinetics and Toxicology of Polyvinylpyrrolidone(Povidone),Lewis publisher, Michigan,1990.
[228]D.J.Bharali,S.K.Sahoo,S.Mozumdar,A.Maitra,Cross-linked polyvinylpyrroli-done nanoparticles:a potential carrier for hydrophilic drugs,J.Colloid Interface Sci.258(2003)415–423.
[229]N.Munshi,T.K.De,A.Maitra,J.Colloid Interface Sci.190(1997)387–391. [230]D.Guowei,K.Adriane,X.Chen,C.Jie,L.Yinfeng,PVP magnetic nanospheres: biocompatibility,in vitro and in vivo bleomycin release,Int.J.Pharm.328(2006) 78–85.
1648M.Hamidi et al./Advanced Drug Delivery Reviews60(2008)1638–1649